FDA
-
-
-
-
-
-
-
Vifor Pharma reports sustained growth in 2021
-
-
-
-
-
-
-
Cara Therapeutics (CARA), Vifor Pharma Announce FDA Approval of KORSUVA
-
-
-
-
-
-
-
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
-
-
-
-
-
-
-
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
-
-
-
-
-
-
-
VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus
-
-
-
-
-
-
-
Vifor Pharma and Akebia Therapeutics Announce Expansion of License Agreement
-
-
-
-
-
-
-
Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018
-
329,602 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

